📥 FREE DOWNLOAD
For research professionals only — instant download, no payment required
Recovery Research Peptides UK — BPC-157, TB-500 and GHK-CU for UK Laboratory Research
Recovery research peptides UK suppliers serve a defined laboratory research category: synthetic compounds investigated in tissue-related research models, regenerative biology research, and cellular signalling research.
The compounds in this category have substantial published research literature, with substantial bodies of in-vitro scientific work covering angiogenesis pathways, growth factor interactions, fibroblast biology, actin sequestration, and copper-dependent cellular research.
Ascend Peptides UK supplies the three principal recovery research peptides in the UK catalogue: BPC-157, TB-500, and GHK-CU. Every batch is HPLC-verified at ≥98% purity, LC-MS confirmed for molecular identity, and independently tested by Janoshik with a publicly verifiable Certificate of Analysis.
The three compounds cover two principal mechanistic classes within recovery research: pentadecapeptides derived from gastric protective protein research (BPC-157), thymosin family peptides involved in cellular and tissue research (TB-500), and copper tripeptide complexes (GHK-CU).
Researchers running multi-compound recovery research programmes can also order the Tri-Regenerative Complex — a single-supplier bundle containing all three compounds — or the Regenesis Complex, which pairs BPC-157 and TB-500 for combined research protocols.
📥 FREE DOWNLOAD
For research professionals only — instant download, no payment required
What Are Recovery Research Peptides?
Recovery research peptides are synthetic compounds used in laboratory research to study cellular and tissue biology pathways relevant to regenerative research models, fibroblast research, angiogenesis research, and copper-dependent cellular research. In the Ascend Peptides UK catalogue, the recovery research peptide category covers three compounds, each representing a distinct mechanistic class:
- Pentadecapeptide research compounds — synthetic peptides derived from gastric protective protein research. BPC-157 (Body Protection Compound 157) is the principal research compound in this class — a 15-amino acid stable gastric pentapeptide widely studied in cellular and tissue research models.
- Thymosin family research peptides — peptides derived from the thymosin protein family. TB-500 is a synthetic fragment of Thymosin Beta-4 (TB-4) with extensive published literature on actin sequestration and cellular migration research.
- Copper tripeptide complex compounds — GHK-CU (glycyl-histidyl-lysine copper) is a copper-bound tripeptide with one of the most substantial published research literatures across both skin biology research and tissue research models.
The mechanistic distinctions matter for experimental design. BPC-157 and TB-500 are the two most studied recovery research compounds and are frequently used together in research protocols — their distinct mechanisms (pentadecapeptide signalling vs actin sequestration) make them complementary research variables rather than redundant compounds.
BPC-157 Research Peptide UK — Pentadecapeptide Research Compound
BPC-157 (Body Protection Compound 157) is a synthetic 15-amino acid peptide derived from a partial sequence of the human gastric protective protein. Molecular formula C62H98N16O22, molecular weight approximately 1419.55 Da. Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. BPC-157 is one of the most extensively studied research peptides in published cellular and tissue research literature, with documented research applications in angiogenesis research, fibroblast biology research, growth factor interaction research, and gastrointestinal cellular research models.
Research Applications of BPC-157
In UK laboratory research, BPC-157 is the standard research compound for pentadecapeptide signalling research. Documented in-vitro research applications include angiogenic factor expression studies in endothelial cell models, fibroblast migration research, collagen gene expression research, and growth hormone receptor interaction studies. BPC-157 is the most published research compound in its mechanistic class and is frequently studied alongside TB-500 in combined recovery research protocols.
BPC-157 is supplied by Ascend Peptides UK at £30 per vial, with HPLC purity verified at ≥98% by Janoshik laboratory, LC-MS molecular identity confirmation, and a batch-specific Certificate of Analysis available pre-purchase. Reconstitute with BP-grade bacteriostatic water and store at −20°C. Browse the BPC-157 product page for batch documentation and same-day UK dispatch.
TB-500 Research Peptide UK — Thymosin Beta-4 Fragment
TB-500 is a synthetic peptide fragment derived from the parent protein Thymosin Beta-4 (TB-4). It corresponds to the active 17-amino acid region of TB-4 responsible for actin sequestration and cellular migration activity. Molecular formula C77H124N24O25, molecular weight approximately 1772.97 Da. TB-500 is the second most studied recovery research peptide after BPC-157 and is the standard research compound for actin-binding pathway research in cellular biology models.
Research Applications of TB-500
Research applications of TB-500 in published UK and international literature include actin sequestration research, cellular migration research, vascular endothelial cell research, and fibroblast activity research in in-vitro cellular models.
TB-500 is the standard research compound when the experimental focus is the actin-binding pathway component of recovery biology research. The compound is structurally and mechanistically distinct from BPC-157; they share only the broad recovery research category, not the underlying mechanism, which makes them complementary research variables rather than redundant compounds.
TB-500 is supplied by Ascend Peptides UK at £35 per vial, with the same Janoshik documentation standard applied across the recovery range. Browse the TB-500 product page for batch documentation, or order the Regenesis Complex (BPC-157 10mg + TB-500 10mg, £55) for combined research protocols.
BPC-157 + TB-500 — Combined Research Protocols
BPC-157 and TB-500 are the most frequently combined compounds in published recovery research peptide literature. The two compounds act through mechanistically distinct pathways (pentadecapeptide signalling vs actin sequestration) and can function as independent variables within the same in-vitro cellular research protocol. Both are stocked together by Ascend Peptides UK with matched Certificate of Analysis documentation. The Regenesis Complex bundle pairs the two compounds at a reduced single-bundle price.
GHK-CU Research Peptide UK — Copper Tripeptide Research Compound
GHK-CU (glycyl-histidyl-lysine copper) is a copper-bound tripeptide complex. Molecular formula C14H22CuN6O4, molecular weight approximately 401.93 Da. The compound consists of the three-amino acid sequence Gly-His-Lys bound to a divalent copper ion (Cu²⁺) through the histidine and lysine residues.
GHK-CU is one of the most extensively characterised research peptides in published literature, with substantial research bodies across both skin biology research models and tissue research models, making it a relevant compound in both the skin and recovery research categories.
Research Applications of GHK-CU
In recovery research model literature, GHK-CU has been studied for its role in fibroblast research, collagen gene expression research, copper-dependent enzyme research, and antioxidant pathway research in cellular models. GHK-CU is the standard research compound when the experimental focus is the copper-dependent component of cellular and tissue research biology. It is structurally and mechanistically distinct from both BPC-157 and TB-500, making it a third independent variable for researchers building multi-compound recovery research programmes.
GHK-CU is supplied by Ascend Peptides UK at £22 per vial, with the same Janoshik documentation standard applied across the recovery range. For researchers running combined three-compound research protocols, the Tri-Regenerative Complex bundle pairs BPC-157, TB-500 and GHK-CU at a reduced single-bundle price of £85 — the most comprehensive recovery research bundle available from Ascend Peptides UK.
Recovery Peptide Supplier UK — How Ascend Peptides UK Documents Every Batch
When sourcing recovery research peptides, UK suppliers must meet four documentation standards that distinguish a verified supplier from an unverified one. These standards are particularly important in the recovery category because BPC-157 and TB-500 are commonly encountered products in the UK research peptide market, making documentation verification important. Supplier quality variation is substantial, and unverified compounds may show variability in independent purity testing. The complete documentation framework is set out on our batch verification page.
|
Documentation Standard |
Industry Norm |
Ascend Peptides UK |
|---|---|---|
|
HPLC purity verification |
Self-reported by the supplier |
Independent HPLC by Janoshik laboratory, ≥98% verified |
|
Molecular identity |
Often not tested |
LC-MS confirmation on every batch |
|
Certificate of Analysis |
Generic or unavailable |
Batch-specific, publicly verifiable, pre-purchase |
|
Storage and dispatch |
3–7 working days |
Same-day UK dispatch before 16:00 GMT, −20°C cold chain |
Every recovery research peptide supplied by Ascend Peptides UK carries a publicly verifiable Janoshik Certificate of Analysis that confirms both HPLC purity (≥98%) and LC-MS molecular identity. The full batch documentation archive is available on the Certificates of Analysis page, and the complete quality control workflow is set out on our ” How We Test Peptides ” page.
Before You Order — Free Research Buyer Starter Pack
The recovery research peptide category, particularly BPC-157 and TB-500, has one of the widest supplier quality variations in the UK research peptide market. Before placing an order for any recovery research peptide, UK research buyers should review the supplier evaluation checklist.
The Research Buyer Starter Pack is a free download from Ascend Peptides UK covering exactly what to verify before ordering, including how to read a Certificate of Analysis, what HPLC and LC-MS results actually confirm, and how to evaluate a UK peptide supplier against measurable standards.
📥 FREE DOWNLOAD
Research Buyer Starter Pack
A practical guide for UK research buyers. What to check before ordering a metabolic research peptide. What documentation to request from any supplier? What storage and dispatch standards to expect.
Inside the checklist:
Inside the pack:
✓ What “research-use only” means under UK regulation
✓ How to evaluate a UK research peptide supplier — 9-point checklist
✓ What documentation to request before purchase (CoA, HPLC, LC-MS)
✓ What storage and reconstitution standards to verify
✓ Pre-order buyer checklist — 16 items to confirm
✓ How to spot a low-quality metabolic peptide supplier — 7 warning signs
For research professionals only — instant download, no payment required
Buy Recovery Research Peptides UK — Documentation Buyer Framework
UK researchers buying recovery research peptides should apply the same documentation framework to every supplier, every batch, and every order. The framework has four steps:
- Step 1 — Verify the Certificate of Analysis is batch-specific and publicly accessible. For BPC-157 and TB-500, both heavily counterfeited in the UK market, a generic CoA that does not name the specific lot number is the single largest red flag.
- Step 2 — Confirm the HPLC purity result is ≥98% and the analytical method is named. “HPLC tested” without a specific purity figure is not a real result.
- Step 3 — Confirm LC-MS molecular identity is reported. HPLC alone confirms purity, but does not confirm what the 98% actually is. LC-MS confirms the molecular weight matches the expected mass of the target peptide.
- Step 4 — Confirm storage and dispatch standards. Lyophilised powder format, −20°C cold chain, same-day or next-day UK dispatch with insulated packaging. Recovery peptides degrade rapidly outside cold-chain handling.
Ascend Peptides UK meets all four standards on every batch of every recovery research peptide supplied. The Janoshik Certificate of Analysis is publicly accessible, the HPLC purity figure is stated on every batch, the LC-MS molecular identity is reported, and all compounds are dispatched same-day before 16:00 GMT in temperature-controlled packaging.
Order Recovery Research Peptides UK — Same-Day Dispatch
The Ascend Peptides UK recovery research peptide range is available for direct order with same-day UK dispatch before 16:00 GMT. Orders over £75 qualify for a free 10ml bacteriostatic water bonus.
For pentadecapeptide research, BPC-157 is the widely researched compound, a 15-amino acid gastric pentapeptide supplied at £30 per vial with HPLC purity verified at ≥98% and Janoshik’s third-party Certificate of Analysis on every batch. BPC-157 is the appropriate research peptide for angiogenesis research, fibroblast biology research, and cellular signalling research in in-vitro models.
For thymosin family recovery research, TB-500 is the standard research compound a 17-amino acid synthetic fragment of Thymosin Beta-4, supplied at £35 per vial with the same documentation standard applied across the Ascend Peptides UK recovery range.
TB-500 is the appropriate research peptide for actin sequestration research and cellular migration research. Researchers running the most common combined recovery research protocol, BPC-157 plus TB-500, can order the Regenesis Complex bundle, which pairs both compounds at the reduced single-bundle price of £55.
For copper tripeptide research, GHK-CU is the standard research compound, a glycyl-histidyl-lysine copper complex supplied at £22 per vial, relevant to both recovery research models and skin biology research.
Researchers building the most comprehensive three-compound recovery research programme can order the Tri-Regenerative Complex bundle BPC-157, TB-500 and GHK-CU together at £85, the most comprehensive recovery bundle in the Ascend Peptides UK catalogue.
Browse the complete range on the Ascend Peptides UK shop collection, or review the documentation transparency standard applied to every batch on the batch verification page. All orders placed before 16:00 GMT are dispatched same-day via Royal Mail Tracked 24 to UK research addresses.
Recovery Research Peptides UK — Frequently Asked Questions
What are recovery research peptides?
Recovery research peptides are synthetic compounds used in laboratory research to study cellular and tissue biology pathways. In the Ascend Peptides UK catalogue, the category covers three principal compounds: BPC-157 (a pentadecapeptide), TB-500 (a Thymosin Beta-4 fragment), and GHK-CU (a copper tripeptide). All are supplied strictly for in-vitro laboratory research.
What is the difference between BPC-157 and TB-500?
BPC-157 is a 15-amino acid pentadecapeptide derived from gastric protective protein research. TB-500 is a 17-amino acid fragment of Thymosin Beta-4. They are mechanistically distinct compounds. BPC-157 acts through pentadecapeptide signalling pathways, while TB-500 acts through actin sequestration. The two compounds are frequently used together in combined research protocols as independent variables. For full comparison details, see the TB-500 vs BPC-157 research peptide comparison guide.
Can I order BPC-157, TB-500 and GHK-CU together?
Yes, three bundle options are available. The Regenesis Complex pairs BPC-157 and TB-500 (£55). The Tri-Regenerative Complex pairs BPC-157, TB-500 and GHK-CU (£85). All bundle products are supplied with the same Janoshik documentation standard applied to individual product orders, and single-supplier batch matching may help support consistency across combined research protocols for combined research protocols.
What is GHK-CU, and why is it studied in recovery research?
GHK-CU (glycyl-histidyl-lysine copper) is a copper-bound tripeptide complex. GHK-CU is studied in recovery research model literature for its role in fibroblast research, collagen gene expression research, copper-dependent enzyme research, and antioxidant pathway research in cellular models. It is one of the most extensively characterised research peptides in published literature.
What is the WADA status of recovery research peptides?
BPC-157 is listed on the World Anti-Doping Agency (WADA) Prohibited List under category S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics) and is prohibited at all times. TB-500 (Thymosin Beta-4) is similarly classified under S2 and prohibited at all times. Researchers should consult the current WADA Prohibited List for the most up-to-date classification of any specific compound.
How should recovery research peptides be stored?
Lyophilised recovery research peptides should be stored at −20°C in the original sealed container. Following reconstitution with BP-grade bacteriostatic water, the reconstituted compound should be stored at 2–8°C and used within the research literature-recommended timeframe for each specific compound.
What is the MHRA status of recovery research peptides in the UK?
Recovery research peptides supplied by Ascend Peptides UK are not licensed as medicinal products under the UK Human Medicines Regulations 2012. They are supplied strictly for in-vitro laboratory research. The Medicines and Healthcare products Regulatory Agency (MHRA) is the relevant medicines regulator in the UK post-Brexit.
Why UK Researchers Source Recovery Research Peptides from Ascend Peptides UK
- ≥98% HPLC purity on every batch — independently verified by Janoshik laboratory
- LC-MS molecular identity confirmation — critical for heavily counterfeited compounds like BPC-157 and TB-500
- Publicly verifiable Certificate of Analysis — batch-specific, available pre-purchase
- Same-day UK dispatch before 16:00 GMT — Royal Mail Tracked 24
- FREE 10ml bacteriostatic water on orders over £75
- Bundle pricing — Regenesis Complex (£55) and Tri-Regenerative Complex (£85)
- All three recovery compounds stocked together — single-supplier batch matching
- Scientific content reviewed by an MBBS-qualified medical reviewer
RESEARCH USE ONLY
All products supplied by Ascend Peptides UK are intended strictly for in-vitro laboratory research purposes only. Compounds are not licensed as medicinal products under the UK Human Medicines Regulations 2012 and are not for human or veterinary use. No dosing guidelines are provided. Products are supplied to qualified research professionals only.
📥 FREE DOWNLOAD
For research professionals only — instant download, no payment required
